Skip to Content

M 615 (Levetiracetam 500 mg)

Pill with imprint M 615 is White, Capsule-shape and has been identified as Levetiracetam 500 mg. It is supplied by Mylan Pharmaceuticals Inc..

Levetiracetam is used in the treatment of seizures; epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 615

Levetiracetam

Imprint
M 615
Strength
500 mg
Color
White
Size
17.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Pyrrolidine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, polydextrose, sodium lauryl sulfate, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-5615 Mylan Pharmaceuticals Inc.
51079-0821 UDL Laboratories Inc.
33261-0645 Aidarex Pharmacuticals, LLC (repackager)

Get help with Imprint Code FAQs.

Related Images for "M 615"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.